Programme de conférences - 2024

Subpage hero

    

Loading

Welcome to Menotopia, the kickstart

09 mars 2024
Aires Thérapeutiques
Welcome to Menotopia, the kickstart

 

 

 

 

 

 

Respected Colleagues, 
 
As we gather for our first conference, I bring attention to the letter ""A."" that refers to Accelerate.
 
Before you read this long synopsis, I want you please to search for ""Midlife Transition Crisis"" 
 
Welcome back,
 
Don't worry, be happy :) 
 
This is our first conference in Paris & it goes beyond just a discussion; This is a call to accelerate R&D, an important effort to unveil the complexities of the midlife transition.
 
I stand before you as a pharmacist with the goal of bridging the knowledge gap for menopause and andropause ( Wrong terms but anyway ). 
 
Although not classified as diseases, inadequate understanding and treatment can pave the way for serious health complications ranging from osteoporosis to heart issues to breast cancer and the list goes on.
 
 
Let us, as healthcare professionals, propel our collective efforts toward a future where individuals possess knowledge about their physiology, physiopathology, and the medications they consume, aiming to restore body balance in peace. I prefer saying; live in peace than rest in peace, you prefer too ?
 
But let's get to know each other first, you probably don't know me. 
 
If you can't spell my name, you can just call me "G"

 

Speakers
Mohammed Ghazali Brahma, Pharmacien - GHG Europe - GMB Health Group
‘Voir tout le programme de conférence - 2024

Les partenaires

PARTENAIRES INSTITUTIONNELS


 

PARTENAIRES PEDAGOGIQUES


 

LES GROUPEMENTS


 

PARTENAIRES MEDIA OFFICIELS


 

PARTENAIRES MEDIA OFFICIELS


 

PARTENAIRES MEDIA


 

PARTENAIRE REMPLACEMENT


 

PARTENAIRE HEBERGEMENT


 

PARTENAIRE RADIO


 

PARTENAIRE MEDIA DOM


 

INDUSTRIE PHARMACEUTIQUE


 

PARTENAIRE PRODUITS BIO


 

Abonnez-vous à notre newsletter PharmagoraPlus !

Etes-vous un robot ? Merci de cocher les cases nécessaires pour confirmer votre inscription.